Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

APE1-Mediated Transcriptional Reprogramming in Esophageal Adenocarcinoma Cells under Acidic Bile Reflux Stress

ABSTRACT: Esophageal adenocarcinoma (EAC) arises in the setting of Barrett's esophagus, an intestinal metaplastic precursor lesion that can develop in patients with chronic Gastroesophageal reflux disease (GERD). This study investigates the genome-wide transcriptional adaptations and molecular stress responses mediated by Apurinic/apyrimidinic endonuclease 1 (APE1) in EAC cells under reflux-induced stress. By utilizing APE1 genetic silencing alongside exposure to an acidic bile salt (ABS), this dataset defines the global differential gene expression profiles, altered signaling pathways, and transcriptional networks that depend on APE1 for survival during reflux stress.

ORGANISM(S): Homo sapiens

PROVIDER: GSE342322 | GEO | 2026/08/06

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Chronic Reflux Stress Reshapes the EAC Transcriptional Landscape via APE1

Project description:Gastroesophageal reflux disease (GERD) is the predominant risk factor for the development of Barrett’s esophagus and esophageal adenocarcinoma (EAC). However, the molecular mechanisms driving responses to chronic reflux conditions in EAC remain poorly defined. This study investigates the genome-wide transcriptional reprogramming and molecular stress responses mediated by apurinic/apyrimidinic endonuclease 1 (APE1) in EAC cells (OE33) surviving chronic, reflux-induced stress. By pairing a 15-day repeated acidified bile salt (rABS) exposure model with subsequent APE1 genetic silencing, this dataset defines the global differential gene expression profiles, altered signaling pathways, and transcriptional networks that depend on APE1 for acquired stress tolerance during sustained reflux insults.

2026-08-11 | GSE342970 | GEO

Transcriptional regulation of APE1-redox Axis in Esophageal adenocarcinoma

Project description:Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) plays an essential role in ROS-sensitive transcriptional regulation in esophageal adenocarcinoma (EAC). While the redox function of APE1 is known to modulate the activity of multiple transcription factors, its global downstream targets in EAC remain to be fully characterized. This study investigates APE1-redox-dependent transcriptional regulation by targeting OE33 cells with the APE1-redox-specific inhibitor, APX2009, to map the underlying gene expression networks.

2026-08-05 | GSE342315 | GEO

Transcriptional Remodeling of Esophageal Adenocarcinoma Cells Under Reflux Conditions

Project description:Gastroesophageal reflux disease (GERD) is the leading risk factor for esophageal adenocarcinoma (EAC), a malignancy that exhibits marked resistance to chemotherapy and results in poor clinical outcomes. This study investigates the genome-wide transcriptional adaptations and downstream molecular stress responses of EAC cells following exposure to acidic bile salts (ABS) to mimic the reflux conditions of GERD. The primary objective of this dataset is to define the differential gene expression profiles, altered signaling pathways, and transcriptional networks activated by acute ABS exposure in an EAC model.

2026-08-06 | GSE342254 | GEO

An APE1 Inhibitor Reveals Critical Roles of APE1 Redox Function in Pathogenesis of Chronic Rhinosinusitis and Novel Therapeutics

Project description:We demonstrated that the Apurinic/apyrimidinic endonuclease 1 (APE1) redox inhibitor, C10, effectively blocked Type 2 inflammation and improved chronic rhinosinusitis (CRS) pathology in a mouse model.

2025-07-01 | GSE285228 | GEO

An APE1 Inhibitor Reveals Critical Roles of APE1 Redox Function in Pathogenesis of Chronic Rhinosinusitis and Novel Therapeutics

2025-07-01 | GSE284612 | GEO

APE1 controls DICER expression through functional regulation of miRNA33a: a novel hypothesis for NSCLC cancer progression [RNA-Seq]

Project description:The overexpression of the DNA repair protein apurinic/apyrimidinic endonuclease 1 (APE1) is an important cause of poor outcome and its expression is able to predict the progression-free and overall survival in patients receiving platinum-containing chemotherapy. Recently, we have demonstrated APE1 involvement in miRNA biogenesis related to cancer progression.

2022-08-03 | GSE166664 | GEO

The DNA-repair protein APE1 contributes with hnRNPA2B1 to motif-enriched miRNA secretion

Project description:The base excision repair (BER) Apurinic/apyrimidinic endonuclease 1 (APE1) enzyme is endowed with several non-repair activities, such as the cell response to genotoxic stress, the regulation of gene expression and miRNAs processing. We recently demonstrated that APE1 can be actively secreted by mammalian cells through exosomes. The role of APE1 in exosomes is still unknown, especially regarding the molecular mechanism involving small non-coding RNAs vesicular secretion. miRNAs loading into exosomes is a regulated and selective process, since not all the expressed miRNAs are indistinctly conveyed into exosomes. Through a dedicated transcriptomic analysis on cellular and vesicular small RNAs, we identified secreted miRNAs characterized by enriched sequence motifs and possible binding sites for APE1. In 50 out of 53 DE-miRNA precursors, we surprisingly found EXO motifs and proved that APE1 cooperates with hnRNPA2B1 for the EV-sorting of a subsets of miRNAs, including miR-1246, through a direct binding to GGAG stretch. We provide evidence of a new post-transcriptional role for this ubiquitous DNA-repair enzyme towards miRNAs secretion mechanisms, that could be exploited to interfere with tumor microenvironment.

2024-07-24 | GSE230874 | GEO

APE1 (apurinic/apyrimidinic endonuclease 1): newly identified post-translational modifications (PTMs)

Project description:APE1 (apurinic/apyrimidinic endonuclease 1) is a multifunctional protein essential for both DNA base excision repair and redox signaling. However, its post-translational modifications (PTMs), which are key to modulating its cellular functions, remain largely uncharacterized due to their dynamic and labile nature. In this study, we developed a novel biotin-regulated avidin-based magnetic nanoparticle platform (bMIPAPE1) that selectively captures active APE1 from living cells under native conditions. This approach preserves labile PTMs and enables downstream mass spectrometry-based proteomic analysis. Using this tool, we identified 27 previously unreported PTMs at 18 distinct residues, including modifications with critical functional implications, such as phosphorylation at Y269 and dual acetylation/palmitoylation at K228. Furthermore, we uncovered PTMs associated with subcellular localization, including modifications at K203, C208, and K63 that correlated with APE1 nuclear export. Beyond enrichment and profiling, bMIPAPE1 also inhibits the enzymatic functions of APE1 in cells, offering potential therapeutic relevance. This project showcases an innovative method for real-time PTM profiling of endogenous proteins in complex cellular environments, with implications for cancer biology and targeted drug discovery.

2026-03-17 | PXD067266 | Pride

APE1 regulates the transcription of urea cycle genes through stabilizing DNA G-quadruplexes in lung adenocarcinoma [ATAC-seq]

Project description:Lung adenocarcinoma (LUAD) remains the leading cause of cancer deaths worldwide. Apurinic/apyrimidinic endonuclease 1 (APE1), an enzyme integral to DNA repair and redox signaling, is notably upregulated in various cancers, including LUAD. Here we reveal that APE1 amplification, primarily via allele duplication, correlates with poor prognosis in LUAD patients strongly. Using human LUAD cell models and a KRAS-driven genetically engineered mouse model (GEMM), we show that APE1 deletion hampers cell proliferation and tumor growth, highlighting its role in tumorigenesis. Mechanistically, APE1 promoted the transcription of urea cycle genes CPS1 and ARG2 by modulating the presence of G-quadruplex (G4) structures in their promoter regions. Loss of APE1 disrupts the urea cycle and pyrimidine metabolism, inducing metabolic reprogramming and growth arrest, which can be rescued by CPS1 or pyrimidine restoration. These findings uncover APE1’s role in metabolic regulation via G4-mediated transcription, providing a potential therapeutic target LUAD patients with elevated APE1 expression.

2024-12-06 | GSE271726 | GEO

APE1 regulates the transcription of urea cycle genes through stabilizing DNA G-quadruplexes in lung adenocarcinoma [SMART-Seq2]

2024-12-06 | GSE245172 | GEO